APRE Competitors & Alternatives
Compare Aprea Therapeutics Inc with similar stocks in the same industry
Biotechnology
APRE
Main Stock$0.44
Tradestie Score
43
Market Cap
$8.50M
Revenue Growth
-1.0%
Analyst Upside
+649.7%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.01
|
$154.27M | - | 41 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.83
|
$133.50M | - | 29 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$32.02
|
$117.07M | - | 30 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$32.05
|
$110.20M | - | 41 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.56
|
$97.42M | - | 50 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.23
|
$84.52M | - | 41 | Compare |
|
BYSI
BeyondSpring Inc. Ordinary Shares
|
$0.65
|
$72.18M | - | 31 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.20
|
$67.94M | - | 46 | Compare |
|
KRSA
KRSA
|
$31.41
|
- | - | 49 | Compare |
|
ATXI
ATXI
|
- | - | - | - | Compare |
More APRE Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry